Eli Lilly and Company, a renowned global pharmaceutical corporation, has made significant breakthroughs in the discovery, development and distribution of human pharmaceuticals all around the world. Among its remarkable offerings are various insulin products such as Basaglar, Humalog, Humalog Mix 75/25, insulin lispro, and Humulin for diabetes, as well as Jardiance, Trajenta and Trulicity for type 2 diabetes. The company also provides innovative treatments for a range of diseases, including Alimta for non-small cell lung cancer and malignant pleural mesothelioma, Cyramza for metastatic cancer, Erbitux for colorectal cancers and various head and neck cancers, and Verzenio for HR+, HER2- metastatic breast cancer, node positive and early breast cancer. Moreover, Eli Lilly and Company offers medications for other diseases, such as Olumiant for rheumatoid arthritis, Cymbalta for depressive disorder, Emgality for migraine prevention, and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its current treatments also include Bamlanivimab, etesevimab, and Bebtelovimab, all of which are used for COVID-19 cases. In addition, the company collaborates with other companies such as Incyte Corporation, Boehringer Ingelheim Pharmaceuticals, Abcellera Biologics, Junshi Biosciences, Regor Therapeutics Group, Kumquat Biosciences, Entos Pharmaceuticals, and Foghorn Therapeutics. Eli Lilly and Company, founded in 1876, has its headquarters located in Indianapolis, Indiana.